Electrolyte Blood Press.  2016 Dec;14(2):31-34. 10.5049/EBP.2016.14.2.31.

A Case Report of Syndrome of Inappropriate Antidiuretic Hormone Induced by Pregabalin

• Jung YJ
• Lee DY
• Kim HW
• Park HS
• Kim B

• KMID: 2369609
• DOI: http://doi.org/10.5049/EBP.2016.14.2.31

Abstract

The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most common cause of euvolemic hyponatremia, and many medications have been associated with SIADH. Pregabalin is a drug used for the treatment of neuropathic pain, though common adverse effects include central nervous system disturbance, peripheral edema, and weight gain. However, hyponatremia caused by pregabalin has been rarely reported. Here we report a patient with pregabalin-induced hyponatremia who met the criteria for SIADH; after discontinuation of the drug, his condition rapidly improved. This case can help clinicians diagnose and treat new-onset hyponatremia in patients who recently initiated pregabalin therapy.

Keyword

Drug associated syndrome of inappropriate antidiuretic hormone secretion; Hyponatremia; Pregabalin

MeSH Terms

Central Nervous System
Edema
Humans
Hyponatremia
Inappropriate ADH Syndrome
Neuralgia
Pregabalin*
Weight Gain
Pregabalin

Reference

1. Ellison DH, Berl T. The syndrome of inappropriate atidiuresis. N Engl J Med. 2007; 356(20):2064–2072. PMID: 17507705.

2. Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother. 2003; 37:1694–1702. PMID: 14565794.

3. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967; 42:790–806. PMID: 5337379.

4. Spigset O, Hedenmalm K. Hyponatremia and the syndrome of inappropriate antidiuretic horemone secretion (SIADH) induced by psychotropic drugs. Drug Saf. 1995; 12:209–225. PMID: 7619332.

5. Foote EF. Syndrome of inappropriate antidiuretic hormone secretion and diabetes insipidus. In : Tisdale JE, Millder DA, editors. Drug-induced diseases, prevention detection and management. Bethesda, MD: American Society of Health-System Pharmacists;2005. p. 611–624.

6. Rose BD. Causes of the SIADH. In : Rose BD, editor. UpTo Date [electronic database]. Waltham, MA: 2007.

7. Page RL 2nd, Cantu M, Lindenfeld J, Hergott LJ, Lowes BD. Possible heart failure exacerbation associated with pregabalin: case discussion and literature review. J Cardiovasc Med (Hagerstown). 2008; 9(9):922–925. PMID: 18695430.

8. De Smedt RH, Jaarsma T, van den Broek SAJ, Haaijer-Ruskamp FM. Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with post-herpetic neuralgia: a case report. Br J Clin Pharmacol. 2008; 66(2):327–328. PMID: 18507657.

9. Shim JH. Clinical Application of Alpha2-Delta Ligand. Hanyang Med Rev. 2011; 31(2):55–62.

10. Sills GJ. The mechanism of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006; 6(1):108–113. PMID: 16376147.

11. Messerli FH. Vasodilatory edema: a common side effect of antihypertensive therapy. Am J Hypertens. 2001; 14(9):978–979. PMID: 11587169.

12. Sudhagar M, Aneesh B, Nayyar I. Syndrome of inappropriate antidiuretic hormone secretion and pregabalin. J Case Rep. 2014; 4(2):408–411.

13. Blum A, Claudia S, Imad T. Hyponatremia and confusion caused by pregabalin. Isr Med Assoc J. 2009; 11:699–700. PMID: 20108561.